Literature DB >> 18581195

Editorial comment: cancer biology--lessons learned from sarcoma.

John H Healey, Bang H Hoang.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18581195      PMCID： PMC2493008          DOI： 10.1007/s11999-008-0353-x

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  8 in total

1.  Rearrangement of the p53 gene in human osteogenic sarcomas.

Authors:  H Masuda; C Miller; H P Koeffler; H Battifora; M J Cline
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Molecule of the year.

Authors:  D E Koshland
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

3.  Cellular homologue (c-src) of the transforming gene of Rous sarcoma virus: isolation, mapping, and transcriptional analysis of c-src and flanking regions.

Authors:  R C Parker; H E Varmus; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

4.  Induction of fibrosarcoma by rat sarcoma virus.

Authors:  S Rasheed; H A Young
Journal:  Virology       Date:  1982-04-15       Impact factor: 3.616

5.  The gene responsible for the development of retinoblastoma and osteosarcoma.

Authors:  W F Benedict; Y K Fung; A L Murphree
Journal:  Cancer       Date:  1988-10-15       Impact factor: 6.860

6.  Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein.

Authors:  S H Friend; J M Horowitz; M R Gerber; X F Wang; E Bogenmann; F P Li; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones.

Authors: 
Journal:  J Bone Joint Surg Am       Date:  2007-10       Impact factor: 5.284

Review 8.  Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571).

Authors:  George D Demetri
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162
  8 in total
  3 in total

1.  Molecular biology and therapeutics in musculoskeletal oncology.

Authors:  Theresa A Guise; Regis O'Keefe; R Lor Randall; Richard M Terek
Journal:  J Bone Joint Surg Am       Date:  2009-03-01       Impact factor: 5.284

2.  Biomarkers in Osteosarcoma.

Authors:  Colin Kong; Marc F Hansen
Journal:  Expert Opin Med Diagn       Date:  2009-01-01

3.  Matrix metalloproteinase 1: role in sarcoma biology.

Authors:  Muhammad Umar Jawad; Nandor Garamszegi; Susanna P Garamszegi; Mayrin Correa-Medina; Juan A Diez; Rong Wen; Sean P Scully
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.